Schedule 13G ownership disclosure
Tenax Therapeutics, Inc.
Common Stock, $0.0001 par value per share · CUSIP: 88032L605
Event date: 2025-12-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Dellora Investments Master Fund LP
Shares: 355,257.00 · Class: 5.7%
- Dellora Investments LP
Shares: 401,071.00 · Class: 6.4%
- Kevin Pyun
Shares: 401,071.00 · Class: 6.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001943462-26-000004
- Form type
- SCHEDULE 13G/A
- Filer
- Dellora Investments LP
- CIK
- CIK 1943462
- Filed
- Feb 17, 2026
- Reporting period
- Dec 31, 2025
- Description
- Schedule 13G beneficial ownership